AngioDynamics reports 8.8% revenue growth driven by high-margin med tech surge
AngioDynamics (NASDAQ:ANGO) on Tuesday reported fiscal second-quarter results that highlighted continued momentum in its high-margin Med Tech portfolio, with overall net sales rising 8.8% year over year to $79.4 million for the period ended Nov. 30, 2025.








-640x358.jpg&w=3840&q=75)


